TrialBritish journal of clinical pharmacology2015

The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions.

Stipo Jurcevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.